Elevance Health has lost its legal battle against the federal government over the way quality ratings are calculated for its Medicare Advantage plans, a decision that cost the insurer roughly $375M in ...

Elevance Health Inc. (NYSE:ELV) is one of the best inexpensive stocks to buy according to hedge funds. On September 4, Elevance’s CFO, Mark Kaye, announced at the Wells Fargo Healthcare Conference in ...

Medicare Part D and Medicare Advantage are undergoing some of their most consequential shifts in years, and the 2025 plan year is where many of those changes crystallize. I focus here on four ...

Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings. Analyst Ann ...

As 2025 draws to a close, Elevance Health highlights how today’ s health plans are evolving to better support their members in a broader range of situations that affect health, including cancer ...

Elevance Health said medical-cost trends played out as expected in the first quarter, contrasting with a disappointing quarterly report from UnitedHealth Group. The Indianapolis insurer is set to ...

Despite elevated medical costs, Elevance Health managed to perform more or less in line with expectations in the first quarter of 2025, bringing in $2.2 billion in profit, a slight decrease from the ...

Elevance Health Inc. (NYSE:ELV) on Tuesday reported first-quarter 2025 revenues of $48.77 billion, up 15% year-over-year, higher than the consensus of $46.29 billion. The increase was driven by higher ...

Elevance Health lowered its profit guidance but held tight on its adjusted earnings target for the year after higher yields and more members boosted first-quarter revenue. The insurer said it now ...

CEO Gail Boudreaux stated that Elevance Health began 2025 with focus and momentum, highlighting investments in patient advocacy solutions supporting over 6 million members with a 95% satisfaction rate ...